Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.2010
+0.0082 (4.25%)
Jun 24, 2026, 5:29 PM CET
Immunovia AB Company Description
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden.
It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual.
Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Immunovia AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Jeff Borcherding |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 4 62 75 60 00 |
| Website | immunovia.com |
Stock Details
| Ticker Symbol | IMMNOV |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0006091997 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jeff Borcherding | Global Chief Executive Officer and President |
| Sarah DeDiemar | Vice President of Sales and Marketing |